Samsung Biologics/Kurma Partners manufacturing partnership

Samsung Biologics and Kurma Partners announce strategic partnership to develop and manufacture biologics for customisable CMC services

Announced by Samsung Biologics and Kurma Partners, the two organisations has established a strategic partnership to develop and manufacture biologics for Kurma Partners’ portfolio companies. 

“We are very excited to partner with Samsung Biologics, a world-leading CDMO with capabilities of highest industry standards. This will greatly benefit our portfolio of Kurma Biofunds and Kurma Growth Opportunities Fund in advancing large molecule biologics from discovery to the market.” said Daniel Parera, M.D., Partner at Kurma Partners. 

What does this mean for Samsung Biologics and Kurma Partners?

Signing a multi-year agreement, Samsung Biologics will provide customisable chemistry, manufacturing, and control (CMC) development services for Kurma Partners’ portfolio companies. 

The agreement will help to:

  • Streamline the gene to the Investigational New Drug (IND) process
  • De-risk uncertainties in CMC
  • Accelerate the lead candidate selection through entry into first-in-human studies with seamless transitions

The portfolio companies will also be able to leverage Samsung Biologics’ state-of-the-art facilities, proprietary technology platforms, and CMC-related expertise.

“As we look to further expand our business opportunities globally, we are pleased to collaborate with Kurma Partners to support the growth of pioneering biotech companies. With our in-depth knowledge of effective scale-up strategy and a diverse portfolio of proprietary platform technologies, we are looking forward to providing robust CMC solutions to reduce uncertainties, ensure regulatory compliance, and ultimately maximize manufacturing efficiency for our clients,” said John Rim, President and CEO of Samsung Biologics.

Investing in emerging biotechs

This latest agreement with Kurma Partners reflects Samsung Biologics’ commitment to supporting emerging biotech companies with drug development and manufacturing, as well as further increasing its business presence in its focus sectors and markets.

*************************************************

Check out our free upcoming virtual event, Manufacturing LIVE, 6th December 2023.

For more insights into Manufacturing - check out the latest edition of Manufacturing Magazine and be sure to follow us on LinkedIn & Twitter.

Other magazines that may be of interest - Healthcare Digital

*********************************************

BizClik is a global provider of B2B digital media platforms that cover 'Executive Communities' for CEO's, CFO's, CMO's, Sustainability Leaders, Procurement & Supply Chain Leaders, Technology & AI Leaders, Cyber Leaders, FinTech & InsurTech Leaders as well as covering industries such as Manufacturing, Mining, Energy, EV, Construction, Healthcare + Food & Drink.

BizClik, based in London, Dubai & New York offers services such as Content Creation, Advertising & Sponsorship Solutions, Webinars & Events.

Share

Featured Articles

Manufacturing EV Charging Solutions at Kempower

Electronics manufacturer Kempower is developing sustainable EV charging technology. COO Sanna Otava explores keeping the supply chain robust

Toyota's Integrated Report 2023: Focus on Manufacturing

Toyota has shared its Integrated Report 2023, on the future of sustainable manufacturing & BEV innovation, as Chairman Akio Toyoda thanks shareholders

Sustainability LIVE Net Zero: Manufacturing & Mobility

Executives across the manufacturing industry have the chance to hear from sustainability leaders, as they explore the future of net zero in manufacturing

Exyn Technologies Launches the Exyn Nexys Modular 3D Mapper

AI & Automation

Rise of European Battery Manufacturing for Electric Vehicles

Technology

ABB Acquires SEAM Group for Industrial Transformation

AI & Automation